Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience

PURPOSE: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome of abnormal phosphate and vitamin D metabolism caused by typically small endocrine tumors that secrete fibroblast growth factor 23 (FGF23). TIO is characterized clinically by progressive musculoskeletal pain, fatigue, proxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahir, Kathryn, Zanchetta, María Belén, Stanciu, Irinel, Robinson, Cemre, Lee, Janet Y, Dhaliwal, Ruban, Charles, Julia, Civitelli, Roberto, Roberts, Mary Scott, Krolczyk, Stan, Weber, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reports and Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282217/
https://www.ncbi.nlm.nih.gov/pubmed/34286168
http://dx.doi.org/10.1210/jendso/bvab099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282217/
https://www.ncbi.nlm.nih.gov/pubmed/34286168
http://dx.doi.org/10.1210/jendso/bvab099

Ejemplares similares